Thirty Companies have Accepted to Join IPG Membership

IPGaia, Inc., (“IPG”) operates IPG membership, which was established with the mission of providing pharmaceutical companies with more efficient access to clinical development drug candidates. We are happy to announce today that the number of member companies accepting IPG membership has exceeded thirty domestic and foreign pharmaceutical companies. Ten out of the thirty member companies are global pharmaceutical companies from abroad, and seven of the fifteen top pharmaceutical companies by revenue in the world (according to our research) have accepted to join the IPG membership. IPG is a platform provider for drug discovery and development in pre-clinical stage, and the company efficiently generates high-quality clinical development candidates from drug discovery …

IP Gaia and PassPort Technologies Announce the Partnership Agreement

PassPort Technologies, Inc. (“PPTI”) and IP Gaia, Inc. (“IPG”) have entered into a business commissioning agreement (the “Agreement”) regarding business development activities aimed at partnerships with third parties for PPTI’s platform technology and development pipeline. Through this Agreement, PPTI will be able to leverage IPG’s network for business development activities. Mr. Tomoyuki Fujisawa, the President and CEO of PPTI, stated, “IPG’s extensive network with numerous global pharmaceutical companies is the ultimate business development capability, and it is like a dream function for venture companies like ours. Through the partnership with IPG, we are confident that we can timely deliver our innovative pharmaceuticals and new technologies to partner companies.” Yasunori Yamaguchi, …

Notice of Capital and Business Alliance with NanoCarrier Co., Ltd.

IPGaia, Inc., (“IPG”) has already concluded a comprehensive business alliance agreement with NanoCarrier Co., Ltd.(“NanoCarrier”) to assume NanoCarrier’s business development function (effective date: March 14, 2023). In order to further strengthen the alliance between the two companies, IPG hereby announces that it has decided to acquire NanoCarrier’s stock acquisition rights through a third-party allotment. Yasunori Yamaguchi, IPG President and CEO, said, “Through this comprehensive business alliance with NanoCarrier since March, IP Gaia is proud to be able to enhance its corporate value as a partner in all business development activities through leveraging IPG’s network, IPG’s established mechanism to capture projects that have been suspended by pharmaceutical companies for strategic reasons …